- ACR
American College of Rheumatology
- ADAPT
Alzheimer’s Disease Anti-Inflammatory Prevention Trial
- AE
Adverse event
- AHRQ
Agency for Healthcare Research and Quality
- ALT
Alanine aminotransferase
- AMI
Acute myocardial infarction
- AMSTAR
Assessment of Multiple Systematic Reviews
- APC
Adenoma Prevention with Celecoxib trial
- ARAMIS
Arthritis, Rheumatism, and Aging Medical Information System
- ARR
Adjusted relative risk
- AST
Aspartate aminotransferase
- CCOHTA
Canadian Coordinating Office for Health Technology Assessment
- CDME
Central Diabetic Macular Edema trial
- CER
Comparative effectiveness review
- CHD
Coronary heart disease
- CHF
Congestive heart failure
- CI
Confidence interval
- CLASS
Celecoxib Long-term Arthritis Safety Study
- CNS
Central nervous system
- COX
Cyclooxygenase
- CV
Cardiovascular
- DMSO
Dimethyl sulphoxide
- EPC
Evidence-based Practice Center
- FDA
Food and Drug Administration
- GI
Gastrointestinal
- GAIT
Glucosamine/chondroitin Arthritis Intervention Trial
- H2
Histamine 2
- HR
Hazard ratio
- HTN
Hypertension
- INR
Immediate release
- JAMA
Journal of the American Medical Association
- JSM
Joint space measurement
- JSN
Joint space narrowing
- JSW
Joint space width
- MeSH
Medical Subject Headings
- MI
Myocardial infarction
- MUCOSA
Misoprostol Ulcer Complications Outcomes Safety Assessment Trial
- NIH
National Institutes of Health
- NNT
Number needed to treat
- NR
Not reported
- NRS LBP
Numerical rating scale for low back pain
- NS
Not significant
- NSAID
Nonsteroidal anti-inflammatory drug
- OA
Osteoarthritis
- OR
Odds ratio
- OMERACT-OARSI
Outcomes Measures in Arthritis Clinical Trials-Osteoarthritis Research Society International
- PCT
Placebo-controlled trial
- PICOTS
Populations, Interventions, Comparators, Outcomes, Timing and Setting
- POBs
Gastric or duodenal perforation, gastric outlet obstruction, or upper gastrointestinal bleeding
- PPI
Proton pump inhibitor
- PreSAP
Prevention of colorectal sporadic adenomatous polyps
- PUBs
Perforations, symptomatic gastroduodenal ulcers, and upper GI bleeding
- PUD
Peptic ulcer disease
- qd
Once a day (quaque die)
- RA
Rheumatoid arthritis
- RCT
Randomized controlled trial
- RMDQ
Roland Morris Disability Questionnaire
- RR
Relative risk
- RRR
Relative risk reduction
- SCHIP
State Children s Health Insurance
- SF-36
Medical Outcomes Short Form-36
- SMD
Standardized mean difference
- SR
Sustained release
- SR
Rystematic review
- SUCCESS-1
Successive Celecoxib Efficacy and Safety Study-1
- TARGET
Therapeutic Arthritis Research and Gastrointestinal Event Trial
- TEP
Technical Expert Panel
- tid
Three times a day (ter in die)
- UGIB
Upper gastrointestinal bleeding
- UK GPRD
United Kingdom General Practice Research Database
- VAS
Visual analog scale
- VIGOR
Vioxx Gastrointestinal Outcomes Research
- WOMAC
Western Ontario and McMaster Universities Osteoarthritis Index
Publication Details
Copyright
Publisher
Agency for Healthcare Research and Quality (US), Rockville (MD)
NLM Citation
Chou R, McDonagh MS, Nakamoto E, et al. Analgesics for Osteoarthritis: An Update of the 2006 Comparative Effectiveness Review [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct. (Comparative Effectiveness Reviews, No. 38.) Acronyms and Abbreviations.